Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor test and the quantiplex HCV RNA 2.0 assay (bDNA)

Journal of Medical Virology

Volumn 55, Issue 3, 1998, Pages 191-196

  Tong, C Y W ^a   Hollingsworth, R C ^b   Williams, H ^a   Irving, W L ^b   Gilmore, I T ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chiron; HCV genotype 1 and nontype 1; HCV RNA concentration; Roche

Indexed keywords

ARTICLE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; QUANTITATIVE DIAGNOSIS; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROTYPING;

CHIRON; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031866101     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199807)55:3<191::AID-JMV2>3.0.CO;2-X     Document Type: Article

References (24)

1. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Saeed AA, Parker D, Yap P-L, Simmonds P (1995): Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. Journal of General Virology 76:1131-1141.
2. Bland M (1995): Regression and correlation. In "An Introduction to Medical Statistics." New York: Oxford University Press, pp 180-203.
3. Bresters, D, Cuypers HTM, Reesink HW, Mauser-Bunschoten EP, Van Den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN (1994): Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in hemophilia patients participating in a controlled interferon trial. Journal of Medical Virology 43:262-268.
4. Chemello L, Cavalletto L, Bernardinello E, Guido M, Pontisso P, Alberti A (1995): The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. Journal of Hepatology 23S2:8-12.
5. Coste J, Montes B, Reynes J, Peeters M, Segarra C, Vendrell JP, Delaporte E, Segondy M (1996): Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. Journal of Medical Virology 50:293-302.
6. Detemer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, Urdea M, Sanchez-Pescador (1996): Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. Journal of Clinical Microbiology 34:901-907.
7. Greenhalgh T (1997): Statistics for the nonstatistician II: "Significant" relations and their pitfalls. British Medical Journal 315: 422-425.
8. Gretch DR, Dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L (1995) : Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications. Annals of Internal Medicine 123:321-329.
9. Hadziyannis E, Fried MW, Nolte FS (1997) Evaluation of two methods for quantitation of hepatitis C virus RNA. Molecular Diagnosis 2:39-46.
10. Hawkins A, Davidson F, Simmonds P (1997): Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. Journal of Clinical Microbiology 35:187-192.
11. Jacob S, Baudy D, Jones E, Xu L, Mason A, Regenstein R, Perrillo RP (1997): Comparison of quantitative HCV RNA assays in chronic hepatitis C. American Journal of Clinical Pathology 107:362-367.
12. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C RNA levels in chronic hepatitis C. Lancet 341: 1501-1504.
13. Lau JYN, Simmonds P, Urdea MS (1995): Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 346:425-426.
14. Mayerat C, Burgisser P, Lavanchy D, Mantegani A, Frei PC (1996): Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation. Journal of Clinical Microbiology 34:2702-2706.
15. Michael N, Robb M, Birx D, Mascola JR, Wang J, Dreyer K, McDonough K, Christopherson C, Lu SD, Kwok S, Herman S (1997): Performance of the Amplicor HIV-1 Monitor test and a modified HIV-1 Monitor test on HIV-1 subtypes A to F. Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections. Washington,DC.
16. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP (1996): Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24:778-789.
17. Pawlotsky J-M (1997) Measuring hepatitis C viremia in clinical ssamples: Can we trust the assays? Hepatology 26:1-4.
18. Roth WK, Lee J-H, Ruster B, Zeuzem S (1996): Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. Journal of Clinical Microbiology 34:261-264.
19. Schvarcz R, Ando Y, Sonnerborg A, Weiland O (1995): Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. Journal of Hepatology 23S2: 17-21.
20. Schuurman R, Descamps D, Weverling GJ, Kaye S, Tijnagel J, Williams I, Van Leeuwen R, Tedder R, Boucher CAB, Brun-Vezinet F, Loveday C (1996): Multicenter comparison of three commercial methods for quantification of human immunodeficency virus type 1 RNA in plasma. Journal of Clinical Microbiology 34:3016-3022.
21. Simmonds P, Rose KA, Graham S, Chan S-W, McOmish F, Dow BC, Follett EAC, Yap PL, Marsden H (1993): Mapping of serotype-specific immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. Journal of Clinical Microbiology 31:1493-1503.
22. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, Urdea M, Yap PL, Simmonds P, The International HCV Collaborative Study Group (1995) Variation of the hepatitis C virus 5′ noncoding region: Implications for secondary structure, virus detection, and typing. Journal of General Virology 76:1749-1761.
23. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M (1996): Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients. Journal of Medical Virology 48:354-359.
24. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K (1994): Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094.